Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan A Hankins

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Medicine|April 28, 2026
Factors Associated With Rectal Spacer Use in Prostate Cancer Patients Receiving Radiation TherapyRyan A Hankins, Kathryn C Morris, Alysha M McGovern, et al.
International Urology and Nephrology|August 13, 2016
Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidneyRyan A Hankins, Annerleim Walton-Diaz, Hong Truong, et al.
Journal of Endourology|September 22, 2016
Repeat Robotic Partial Nephrectomy: Characteristics, Complications, and Renal Functional OutcomesMatthew J Watson, Abhinav Sidana, Annerleim Walton Diaz, et al.
European Urology|June 16, 2020
Retzius-sparing Robot-assisted Radical Prostatectomy Leads to Durable Improvement in Urinary Function and Quality of Life Versus Standard Robot-assisted Radical Prostatectomy Without Compromise on Oncologic Efficacy: Single-surgeon Series and Step-by-step GuideJillian Egan, Shawn Marhamati, Filipe L F Carvalho, et al.
Frontiers in Oncology|January 9, 2023
Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancerRishabh K Simhal, Tamir N Sholklapper, Anish K Simhal, et al.
Frontiers in Oncology|April 8, 2024
Prognostic utility of biopsy-based <i>PTEN</i> and <i>ERG</i> status on biochemical progression and overall survival after SBRT for localized prostate cancerMichael C Repka, Tamir Sholklapper, Alan L Zwart, et al.
Frontiers in Oncology|April 18, 2022
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate CancerMichael C Repka, Michael Creswell, Jonathan W Lischalk, et al.
Frontiers in Oncology|April 11, 2022
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate CancerTamir N Sholklapper, Michael L Creswell, Alexandra T Payne, et al.
Frontiers in Oncology|February 4, 2021
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation TherapyMichael Carrasquilla, Michael L Creswell, Abigail N Pepin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Medicine|April 28, 2026
Factors Associated With Rectal Spacer Use in Prostate Cancer Patients Receiving Radiation TherapyRyan A Hankins, Kathryn C Morris, Alysha M McGovern, et al.
International Urology and Nephrology|August 13, 2016
Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidneyRyan A Hankins, Annerleim Walton-Diaz, Hong Truong, et al.
Journal of Endourology|September 22, 2016
Repeat Robotic Partial Nephrectomy: Characteristics, Complications, and Renal Functional OutcomesMatthew J Watson, Abhinav Sidana, Annerleim Walton Diaz, et al.
European Urology|June 16, 2020
Retzius-sparing Robot-assisted Radical Prostatectomy Leads to Durable Improvement in Urinary Function and Quality of Life Versus Standard Robot-assisted Radical Prostatectomy Without Compromise on Oncologic Efficacy: Single-surgeon Series and Step-by-step GuideJillian Egan, Shawn Marhamati, Filipe L F Carvalho, et al.
Frontiers in Oncology|January 9, 2023
Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancerRishabh K Simhal, Tamir N Sholklapper, Anish K Simhal, et al.
Frontiers in Oncology|April 8, 2024
Prognostic utility of biopsy-based <i>PTEN</i> and <i>ERG</i> status on biochemical progression and overall survival after SBRT for localized prostate cancerMichael C Repka, Tamir Sholklapper, Alan L Zwart, et al.
Frontiers in Oncology|April 18, 2022
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate CancerMichael C Repka, Michael Creswell, Jonathan W Lischalk, et al.
Frontiers in Oncology|April 11, 2022
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate CancerTamir N Sholklapper, Michael L Creswell, Alexandra T Payne, et al.
Frontiers in Oncology|February 4, 2021
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation TherapyMichael Carrasquilla, Michael L Creswell, Abigail N Pepin, et al.
Pageof 1